Comment
Author: Admin | 2025-04-28
PRINCIPAL DISPLAY PANEL PRINCIPAL DISPLAY PANEL PRINCIPAL DISPLAY PANEL PRINCIPAL DISPLAY PANEL TADALAFIL tadalafil tablet, film coated Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42291-864 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TADALAFIL (TADALAFIL) TADALAFIL 2.5 mg Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM HYDROXYPROPYL CELLULOSE, UNSPECIFIED HYPROMELLOSE, UNSPECIFIED LACTOSE MONOHYDRATE MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE SODIUM LAURYL SULFATE TALC TITANIUM DIOXIDE TRIACETIN Product Characteristics Color white Score no score Shape ROUND Size 4mm Flavor Imprint Code C1 Contains Packaging # Item Code Package Description Multilevel Packaging 1 NDC:42291-864-30 30 TABLET, FILM COATED in 1 BOTTLE None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA209744 01/21/2021 TADALAFIL tadalafil tablet, film coated Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42291-865 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TADALAFIL (TADALAFIL) TADALAFIL 5 mg Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM HYDROXYPROPYL CELLULOSE, UNSPECIFIED HYPROMELLOSE, UNSPECIFIED FERRIC OXIDE YELLOW LACTOSE MONOHYDRATE MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE SODIUM LAURYL SULFATE TALC TITANIUM DIOXIDE TRIACETIN Product Characteristics Color yellow Score no score Shape ROUND Size 6mm Flavor Imprint Code A13 Contains Packaging # Item Code Package Description Multilevel Packaging 1 NDC:42291-865-30 30 TABLET, FILM COATED in 1 BOTTLE None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA209744 01/21/2021 TADALAFIL tadalafil tablet, film coated Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42291-866 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TADALAFIL (TADALAFIL) TADALAFIL 10 mg Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM HYDROXYPROPYL CELLULOSE, UNSPECIFIED HYPROMELLOSE, UNSPECIFIED FERRIC OXIDE RED FERRIC OXIDE YELLOW LACTOSE MONOHYDRATE MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE SODIUM LAURYL SULFATE TALC TITANIUM DIOXIDE TRIACETIN Product Characteristics Color yellow Score no score Shape ROUND Size 8mm Flavor Imprint Code AC;06 Contains Packaging # Item Code Package Description Multilevel Packaging 1 NDC:42291-866-30 30 TABLET, FILM COATED in 1 BOTTLE None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA209744 01/21/2021 TADALAFIL tadalafil tablet, film coated Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42291-867 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TADALAFIL (TADALAFIL) TADALAFIL 20 mg Inactive Ingredients Ingredient Name
Add Comment